Company intelligence / Profile preview
Shenzhen TargetRx
Shenzhen, Guangdong, Chinatargetrx.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Shenzhen TargetRx is a clinical-stage biopharmaceutical company dedicated to the discovery and development of next-generation small molecule targeted therapies, with a primary focus on overcoming acquired drug resistance in oncology. The company utilizes a proprietary structure-based drug design platform to develop highly selective inhibitors for validated targets such as ALK, ROS1, and BCR-ABL. Its lead candidates, TGRX-326 and TGRX-678, are currently in clinical development for the treatment of non-small cell lung cancer and chronic myeloid leukemia, respectively. TargetRx aims to address significant unmet medical needs by providing potent therapeutic options for patients who have failed previous lines of targeted therapy.
- Therapeutic areas
- Oncology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
Beyond the preview
Go deeper on Shenzhen TargetRx.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shenzhen TargetRx.